Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Preventing Atopic Dermatitis in High-Risk Children Using Paraffin White Soft Cream

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study on the Safety and Immune Response of mRNA-1345 Vaccine for Respiratory Syncytial Virus in Pregnant Women and Their Infants

    Not recruiting

    2 1 1
    Denmark
  • Study on the Safety and Effectiveness of MK-1654 for Preventing Respiratory Syncytial Virus (RSV) in Healthy Pre-Term and Full-Term Infants

    Not recruiting

    4 1 1
    Belgium Denmark Finland France Italy Poland +1
  • Study on the Effects of Ritlecitinib in Patients Aged 12 and Older with Alopecia Areata

    Not recruiting

    3 1 1
    Investigated Diseases:
    Czechia Poland Spain
  • Study on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Asthma in Patients Aged 12 and Older

    Not recruiting

    3 1
    Investigated Diseases:
    Bulgaria Czechia Germany Poland Romania Slovakia
  • Study Comparing Axatilimab to Best Available Therapy for Patients with Chronic Graft-Versus-Host Disease After Two or More Treatments

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Czechia Finland France Germany +8
  • Study on the Effects of Remibrutinib for Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    3 1 1
    Investigated Diseases:
    Bulgaria Denmark Germany Greece Italy Poland +3
  • Study on the Effectiveness and Safety of Remibrutinib for Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium Czechia France Germany Greece +4
  • Study on the Effectiveness and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab for Patients with Moderate to Severe Plaque Psoriasis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Denmark Germany Hungary Poland +2
  • Study of Bleximenib with Drug Combination for Patients with Acute Myeloid Leukemia with KMT2A or NPM1 Alterations

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    France Germany Italy Spain